Chemicals Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Chemicals Press Releases.

Press releases published on July 23, 2026

Jul. 23, 2026

Elegant Zen Charm of Niushou Mountain: Discover the Most Relaxing Summer Serenity in Nanjing

Indeterminate GlobeNewswire

Jul. 23, 2026

Middlesex Water Company Declares Quarterly Cash Dividend

Indeterminate GlobeNewswire

Jul. 23, 2026

Abivax Strengthens Commercial Capabilities With Strategic Leadership Appointments

Indeterminate GlobeNewswire

Jul. 23, 2026

Abivax renforce ses capacités commerciales avec des nominations stratégiques à des postes clés

Indeterminate GlobeNewswire

Jul. 23, 2026

Roivant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026

Indeterminate GlobeNewswire

Jul. 23, 2026

Dynagas LNG Partners LP Declares Cash Distribution on Its Series A Preferred Units

Indeterminate GlobeNewswire

Jul. 23, 2026

Quest Resource Holding Corporation to Report Second Quarter 2026 Financial Results and Host Earnings Call on August 6, 2026

Indeterminate GlobeNewswire

Jul. 23, 2026

Marten Transport Announces Second Quarter Results

Indeterminate GlobeNewswire

Jul. 23, 2026

Silvaco Announces Date of Second Quarter 2026 Financial Results Conference Call

Indeterminate GlobeNewswire

Jul. 23, 2026

Rigetti Computing to Report Second Quarter 2026 Financial Results and Host Conference Call on August 6, 2026

Indeterminate GlobeNewswire

Jul. 23, 2026

Capital Clean Energy Carriers Corp. Declares Quarterly Dividend

Indeterminate GlobeNewswire

Jul. 23, 2026

Weight Watchers Schedules Second Quarter 2026 Earnings Conference Call

Indeterminate GlobeNewswire

Jul. 23, 2026

Dyne Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares

Indeterminate GlobeNewswire

Jul. 23, 2026

Prime Medicine Announces U.S. FDA Clearance of Investigational New Drug Application for PM577a in H1069Q-mutated Wilson Disease

Indeterminate GlobeNewswire

Jul. 23, 2026

Immunovant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026

Indeterminate GlobeNewswire

Jul. 23, 2026

Digital Realty Reports Second Quarter 2026 Results

Indeterminate GlobeNewswire

Jul. 23, 2026

AppFolio, Inc. Announces Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Jul. 23, 2026

Kiniksa Pharmaceuticals to Report Second Quarter 2026 Financial Results on July 28, 2026

Indeterminate GlobeNewswire

Jul. 23, 2026

Heartflow to Report Second Quarter 2026 Financial Results on August 13, 2026

Indeterminate GlobeNewswire

Jul. 23, 2026

MacroGenics Provides Clinical Update on Ongoing Phase 1 Study for MGC026

Indeterminate GlobeNewswire